Arcadia Biosciences (NASDAQ:RKDA) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a research note published on Saturday. The firm issued a sell rating on the basic materials company’s stock.

Separately, HC Wainwright restated a “buy” rating and issued a $6.00 price target on shares of Arcadia Biosciences in a research report on Wednesday, August 21st.

Arcadia Biosciences Stock Up 5.7 %

Shares of RKDA opened at $2.74 on Friday. The business has a 50-day simple moving average of $3.34 and a two-hundred day simple moving average of $3.05. The stock has a market cap of $3.73 million, a price-to-earnings ratio of -0.64 and a beta of 1.27. Arcadia Biosciences has a 52 week low of $1.85 and a 52 week high of $5.34.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.